{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T12:51:25Z","timestamp":1761310285360},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1986,6,1]],"date-time":"1986-06-01T00:00:00Z","timestamp":517968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J, Clin. Microbiol."],"published-print":{"date-parts":[[1986,6]]},"DOI":"10.1007\/bf02017784","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T07:11:56Z","timestamp":1123830716000},"page":"292-296","source":"Crossref","is-referenced-by-count":2,"title":["In vitro activity of carumonam (RO 17-2301) and twelve other antimicrobials against clinical isolates ofPseudomonas aeruginosa"],"prefix":"10.1007","volume":"5","author":[{"given":"U.","family":"Vurma-Rapp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. -H.","family":"Kayser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02017784_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1128\/JCM.18.1.160-164.1983","volume":"18","author":"R. J. Sherertz","year":"1983","unstructured":"Sherertz, R. J., Sarubbi, F. A.: A three-year study of nosocomial infections associated withPseudomonas aeruginosa. Journal of Clinical Microbiology 1983, 18: 160\u2013164.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF02017784_CR2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/11.6.511","volume":"11","author":"P. Auwera Van der","year":"1983","unstructured":"Van der Auwera, P., Schuyteneer, F.: In-vitro susceptibility ofPseudomonas aeruginosa to old and new beta-lactam antibiotics and aminoglycosides. Journal of Antimicrobial Chemotherapy 1983, 11: 511\u2013515.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017784_CR3","first-page":"240","volume":"244","author":"V. Sticht-Groh","year":"1979","unstructured":"Sticht-Groh, V.: Tracing ofPseudomonas aeruginosa infection by the use of commercial antisera and pyocin production and the evaluation of the results on the basis of the chi-square test. Zentralblatt f\u00fcr Bakteriologie, Mikrobiologie und Hygiene (A) 1979, 244: 240\u2013250.","journal-title":"Zentralblatt f\u00fcr Bakteriologie, Mikrobiologie und Hygiene (A)"},{"key":"BF02017784_CR4","first-page":"189","volume-title":"Resistance ofPseudomonas aeruginosa","author":"T. Bergan","year":"1975","unstructured":"Bergan, T.: Epidemiological typing ofPseudomonas aeruginosa. In: Brown, M. R. W. (ed.): Resistance ofPseudomonas aeruginosa. John Wiley and Sons, London 1975, p. 189\u2013235."},{"key":"BF02017784_CR5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1099\/00222615-2-1-17","volume":"2","author":"J. R. W. Govan","year":"1969","unstructured":"Govan, J. R. W., Gillies, R. R.: Further studies in the pyocine typing ofPseudomonas pyocyanea. Journal of Medical Microbiology 1969, 2: 17\u201325.","journal-title":"Journal of Medical Microbiology"},{"key":"BF02017784_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0580-9517(08)70660-3","volume-title":"Methods in microbiology. Volume 10","author":"J. R. W. Govan","year":"1978","unstructured":"Govan, J. R. W.: Pyocin typing ofPseudomonas aeruginosa. In: Bergan, T., Norris, J. R. (ed.): Methods in microbiology. Volume 10. Academic Press, London, 1978, p. 61\u201391."},{"key":"BF02017784_CR7","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"1985","unstructured":"National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, PA, NCCLS, 1985."},{"key":"BF02017784_CR8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/AAC.20.4.525","volume":"20","author":"A. L. Barry","year":"1981","unstructured":"Barry, A. L., Jones, R. N., Thornsberry, C.: Cefsulodin: antibacterial activity and tentative interpretive zone standards for the disk susceptibility test. Antimicrobial Agents and Chemotherapy 1981, 20: 525\u2013529.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017784_CR9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/jcm.5.6.640-649.1977","volume":"5","author":"C. D. Brokopp","year":"1977","unstructured":"Brokopp, C. D., Gomez-Lus, R., Farmer III, J. J.: Serological typing ofPseudomonas aeruginosa: use of commercial antisera and live antigens. Journal of Clinical Microbiology 1977, 5: 640\u2013649.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF02017784_CR10","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/JCM.16.3.458-463.1982","volume":"16","author":"N. J. Legakis","year":"1982","unstructured":"Legakis, N. J., Aliferopoulou, M., Papavassiliou, J., Papapetropoulou, M.: Serotypes ofPseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility. Journal of Clinical Microbiology 1982, 16: 458\u2013463.","journal-title":"Journal of Clinical Microbiology"},{"key":"BF02017784_CR11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/jac\/12.4.337","volume":"12","author":"P. Y. Chau","year":"1983","unstructured":"Chau, P. Y., Ling, J., Ng, W. S.: Cefoperazone against carbenicillin-resistant isolates ofPseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoylthienamycin. Journal of Antimicrobial Chemotherapy 1983, 12: 337\u2013345.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017784_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/jac\/14.1.9","volume":"14","author":"R. J. Williams","year":"1984","unstructured":"Williams, R. J., Lindridge, M. A., Said, A. A., Livermore, D. M., Williams, J. D.: National survey of antibiotic resistance inPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1984, 14: 9\u201316.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017784_CR13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01977498","volume":"3","author":"J. Righter","year":"1984","unstructured":"Righter, J.: In vitro activity of ciprofloxacin, azthreonam and ceftazidime againstSerratia marcescens andPseudomonas aeruginosa. European Journal of Clinical Microbiology 1984, 3: 368\u2013369.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02017784_CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02013604","volume":"4","author":"B. Wiedemann","year":"1985","unstructured":"Wiedemann, B., Machka, K., Malottke, R.: Multicenter study of the sensivity ofPseudomonas aeruginosa to antimicrobial agents. European Journal of Clinical Microbiology 1985, 4: 229\u2013230.","journal-title":"European Journal of Clinical Microbiology"},{"key":"BF02017784_CR15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/AAC.27.5.872","volume":"27","author":"W. W. S. Ng","year":"1985","unstructured":"Ng, W. W. S., Chau, P. Y., Leung, Y. K., Livermore, D. M.: In vitro activities of RO 17-2301 and azthreonam compared with those of other new beta-lactam antibiotics against clinical isolates ofPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1985, 27: 872\u2013873.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017784_CR16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000238350","volume":"31","author":"C. J. Fernandes","year":"1985","unstructured":"Fernandes, C. J., Stevens, D. A., Ackermann, V. P.: Comparative antibacterial activities of new beta-lactam antibiotics againstPseudomonas aeruginosa. Chemotherapy 1985, 31: 292\u2013296.","journal-title":"Chemotherapy"},{"key":"BF02017784_CR17","volume-title":"Performance standards for antimicrobial disk susceptibility tests","author":"National Committee for Clinical Laboratory Standards","year":"1984","unstructured":"National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Villanova, PA, NCCLS, 1984."},{"key":"BF02017784_CR18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jac\/8.5.355","volume":"8","author":"D. M. Livermore","year":"1981","unstructured":"Livermore, D. M., Williams, R. J., Williams, J. D.: Invitro activity of MK0787 (N-formimidoyl thienamycin) againstPseudomonas aeruginosa and other gramnegative organisms and its stability to their betalactamases. Journal of Antimicrobial Chemotherapy 1981, 8: 355\u2013362.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017784_CR19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1128\/AAC.28.1.41","volume":"28","author":"F. Tausk","year":"1985","unstructured":"Tausk, F., Evans, M. E., Patterson, L. S., Federspiel, C., Stratton, C. W.: Imipenem-induced resistance to antipseudomonal beta-lactams inPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1985, 28: 41\u201345.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017784_CR20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/AAC.27.1.84","volume":"27","author":"F. Yoshimura","year":"1985","unstructured":"Yoshimura, F., Nikaido, H.: Diffusion of bcta-lactam antibiotics through the porin channels ofEscherichia coli K 12. Antimicrobial Agents and Chemotherapy 1985, 27: 84\u201392.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"BF02017784_CR21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jac\/8.4.323","volume":"8","author":"D. M. Livermore","year":"1981","unstructured":"Livermore, D. M., Williams, R. J., Williams, J. D.: Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone againstPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1981, 8: 323\u2013331.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017784_CR22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/10.3.168","volume":"10","author":"D. M. Livermore","year":"1982","unstructured":"Livermore, D. M.: Beta-lactamases ofPseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 1982, 10: 168\u2013171.","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF02017784_CR23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/MMBR.47.3.361-409.1983","volume":"47","author":"T. J. Forster","year":"1983","unstructured":"Forster, T. J.: Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiological Reviews 1983, 47: 361\u2013409.","journal-title":"Microbiological Reviews"},{"key":"BF02017784_CR24","first-page":"789","volume":"10","author":"M. J. Rivera","year":"1984","unstructured":"Rivera, M. J., Vitoria, M. A., Navarro, M., Robledano, L., Chocarro, P., Gomez Lus, R.: Hospital dissemination among gram-negative bacillus strains of an inc M plasmid encoding an AAC (3) and a TEM-1 betalactamase. Drugs under Experimental and Clinical Research 1984, 10: 789\u2013795.","journal-title":"Drugs under Experimental and Clinical Research"},{"key":"BF02017784_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0147-619X(79)90004-0","volume":"2","author":"G. A. Jacoby","year":"1979","unstructured":"Jacoby, G. A., Matthew, M.: The distribution of beta-lactamase genes on plasmids found inPseudomonas. Plasmid 1979, 2: 41\u201347.","journal-title":"Plasmid"},{"key":"BF02017784_CR26","first-page":"329","volume":"134","author":"F. W. Goldstein","year":"1983","unstructured":"Goldstein, F. W., Gutmann, L., Williamson, R., Collatz, E., Acar, J. F.: In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain ofSerratia marcescens. Annales de Microbiologic (A) 1983, 134: 329\u2013337.","journal-title":"Annales de Microbiologic (A)"},{"key":"BF02017784_CR27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/AAC.20.5.702","volume":"20","author":"P. R. Michael","year":"1981","unstructured":"Michael, P. R., Alford, R. H., McGee, Z. A.: Superior activity of N-formimidoyl thienamycin against gentamicin-resistantPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 1981. 20: 702\u2013704.","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["European Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02017784.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02017784\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02017784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T11:36:11Z","timestamp":1626348971000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02017784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1986,6]]}},"alternative-id":["BF02017784"],"URL":"https:\/\/doi.org\/10.1007\/bf02017784","relation":{},"ISSN":["0722-2211","1435-4373"],"issn-type":[{"value":"0722-2211","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,6]]}}}